Bachem Holding AG (SWX: BANB)

Market Cap	5.11B
Revenue (ttm)	577.77M
Net Income (ttm)	113.57M
Shares Out	74.97M
EPS (ttm)	1.52
PE Ratio	44.95
Forward PE	39.51
Dividend	0.80 (1.17%)
Ex-Dividend Date	n/a

Volume	84,880
Open	67.60
Previous Close	68.10
Day's Range	67.45 - 68.55
52-Week Range	53.95 - 91.65
Beta	0.72
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 27, 2025

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Chemicals
• Sector: Materials
• Founded: 1971
• Employees: 2,006
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: BANB

Financial Performance

In 2023, Bachem Holding AG's revenue was 577.32 million, an increase of 8.57% compared to the previous year's 531.74 million. Earnings were 111.86 million, an increase of 11.10%.